Fahreddin Palaz

9PUBLICATIONS
25CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsSensor technology (incl. chemical aspects)Empirical software engineeringVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.

|Jun 04, 2024
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma.

Fahreddin Palaz, Mehmet Ozsoz, Ali Zarrinpar

|Apr 18, 2024
Clinical Validation and Evaluation of a Colorimetric SARS-CoV-2 RT-LAMP Assay Against RT-PCR.

Murat Erdem, Ayşe Andaç-Özketen, Ahmet Çağlar Özketen

|Feb 01, 2024
Applications of CRISPR Epigenome Editors in Tumor Immunology and Autoimmunity.

Berkay Yahsi, Fahreddin Palaz, Pervin Dincer

|Apr 15, 2022
A Highly Potent SARS-CoV-2 Blocking Lectin Protein.

Recep E Ahan, Alireza Hanifehnezhad, Ebru Ş Kehribar

|Sep 28, 2021
RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods.

Kasturi Selvam, Mohamad Ahmad Najib, Muhammad Fazli Khalid

Pageof 2

Frequent Collaborators

4 joint publications

Mehmet Ozsoz

2 joint publications

Abdullah Tozluyurt

1 joint publications

Ezgi Kivrak

1 joint publications

Nikki A Copeland